Nucleus Pulposus‐Targeting Nanocarriers Facilitate Mirna‐Based Therapeutics for Intervertebral Disc Degeneration
Advanced Healthcare Materials · 2023-11 · 12 (28)
DOI: 10.1002/adhm.202301337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.09.2023. Verfasst von Zhonghui Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350000, China. Hauptthemen laut MEDLINE: MicroRNAs, Intervertebral Disc Degeneration, Nucleus Pulposus. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Intervertebral disc degeneration (IDD) is a common cause of low back pain. Understanding its molecular mechanisms is the basis for developing specific treatment. To demonstrate that miR‐22‐3p is critical in the regulation of IDD, miRNA microarray analyses are conducted in conjunction with in vivo and in vitro experiments. The miR‐22‐3p knockout (KO) mice show a marked decrease in the histological scores. Bioinformatic analysis reveals that miR‐22‐3p plays a mechanistic role in the development of IDD by targeting SIRT1, which in turn activates the JAK1/STAT3 signaling pathway. This is confirmed by a luciferase reporter assay and western blot analysis. Therapeutically, the delivery of miR‐22‐3p inhibitors and mimics through the synthesized nanoparticles in the IDD model alleviates and aggravates IDD, respectively. The nanocarriers enhance transportation of miR‐22‐3p to nucleus pulposus cells, thus enabling the in vivo inhibition of miR‐22‐3p for therapeutic purposes and consequently promoting the development of miRNA‐specific drugs for IDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Orthopaedic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350000, China.
- Orthopaedic Surgery, Fuzhou Second Hospital, Fuzhou, Fujian, 350000, China.
- Orthopaedic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430000, China.
- Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, 350000, China.
- Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou, Fujian, 350000, China.
- Department of Sport's Medicine, The Second Affiliated Hospital of Fujian Traditional Chinese Medical University, Fuzhou, Fujian, 350000, China.
ORCID-Profile: Weiliang Cui
Förderung
- Natural Science Foundation of Fujian Province
Zitieren
APA
Chen, Z., Liao, Z., Liu, M., Lin, F., Chen, S., Wang, G., Zheng, Z., Liu, B., Li, C., Wang, Z., Chen, T., Huang, H., Liao, Q., & Cui, W. (2023). Nucleus Pulposus‐Targeting Nanocarriers Facilitate Mirna‐Based Therapeutics for Intervertebral Disc Degeneration. Advanced Healthcare Materials, 12(28). https://doi.org/10.1002/adhm.202301337
Vancouver
Chen Z, Liao Z, Liu M, Lin F, Chen S, Wang G, et al. Nucleus Pulposus‐Targeting Nanocarriers Facilitate Mirna‐Based Therapeutics for Intervertebral Disc Degeneration. Advanced Healthcare Materials. 2023;12(28). doi:10.1002/adhm.202301337
BibTeX
@article{Chen2023,
author = {Chen, Zhonghui and Liao, Zhong and Liu, Ming and Lin, Fengfei and Chen, Shunyou and Wang, Geng and Zheng, Zhong and Liu, Boling and Li, Chaoxiong and Wang, Zheqiang and Chen, Tianlai and Huang, Hongzhe and Liao, Qi and Cui, Weiliang},
title = {Nucleus Pulposus‐Targeting Nanocarriers Facilitate Mirna‐Based Therapeutics for Intervertebral Disc Degeneration},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {28},
doi = {10.1002/adhm.202301337}
}
EUVIMED